Assignee
KARYOPHARM THERAPEUTICS INC
US·38 granted patents·15 pending applications·482 citations·filing 2013–2025
Top patents by PatentIndex Score
53 records- 0198US11807629B2Polymorphs of SelinexorKARYOPHARM THERAPEUTICS INC·Filed 2021·Granted Nov 7, 2023·6 cites·7 claims
- 0298US11787771B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2021·Granted Oct 17, 2023·5 cites·12 claims
- 0398US11753401B2Polymorphs of SelinexorKARYOPHARM THERAPEUTICS INC·Filed 2023·Granted Sep 12, 2023·5 cites·23 claims
- 0498US11746102B2Polymorphs of selinexorKARYOPHARM THERAPEUTICS INC·Filed 2023·Granted Sep 5, 2023·5 cites·17 claims
- 0597US12291508B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2023·Granted May 6, 2025·2 cites·15 claims
- 0697US11078190B2Polymorphs of selinexorKARYOPHARM THERAPEUTICS INC·Filed 2019·Granted Aug 3, 2021·11 cites·20 claims
- 0797US11034660B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2019·Granted Jun 15, 2021·10 cites·13 claims
- 0897US10519139B2Polymorphs of SelinexorKARYOPHARM THERAPEUTICS INC·Filed 2015·Granted Dec 31, 2019·17 cites·28 claims
- 0997US10173987B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2017·Granted Jan 8, 2019·18 cites·12 claims
- 1097US9861614B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2015·Granted Jan 9, 2018·27 cites·19 claims
- 1197US9714226B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2015·Granted Jul 25, 2017·28 cites·8 claims
- 1297US9585874B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2016·Granted Mar 7, 2017·27 cites·19 claims
- 1397US9266843B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2013·Granted Feb 23, 2016·31 cites·6 claims
- 1497US9206158B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2015·Granted Dec 8, 2015·28 cites·2 claims
- 1597US9096543B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2013·Granted Aug 4, 2015·35 cites·35 claims
- 1697US8999996B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2014·Granted Apr 7, 2015·44 cites·2 claims
- 1796US10544108B2Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2018·Granted Jan 28, 2020·14 cites·7 claims
- 1895US11945794B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2021·Granted Apr 2, 2024·4 cites·18 claims
- 1995US11124493B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2019·Granted Sep 21, 2021·12 cites·10 claims
- 2094US10709706B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2016·Granted Jul 14, 2020·11 cites·34 claims
- 2194US10407405B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2017·Granted Sep 10, 2019·21 cites·19 claims
- 2293US12371420B2Polymorphs of SelinexorKARYOPHARM THERAPEUTICS INC·Filed 2023·Granted Jul 29, 2025·1 cites·14 claims
- 2393US9738624B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2014·Granted Aug 22, 2017·29 cites·19 claims
- 2493US9550757B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2013·Granted Jan 24, 2017·24 cites·25 claims
- 2592US10202366B2Methods of promoting wound healing using CRM1 inhibitorsKARYOPHARM THERAPEUTICS INC·Filed 2014·Granted Feb 12, 2019·22 cites·6 claims
- 2691US10526295B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2016·Granted Jan 7, 2020·12 cites·20 claims
- 2788US10399963B2Substituted benzofuranyl and benzoxazolyl compounds and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2017·Granted Sep 3, 2019·5 cites·17 claims
- 2887US9994558B2Multicyclic compounds and methods of using sameKARYOPHARM THERAPEUTICS INC·Filed 2014·Granted Jun 12, 2018·6 cites·17 claims
- 2987US9856241B2Substituted benzofuranyl and benzoxazolyl compounds and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2014·Granted Jan 2, 2018·8 cites·16 claims
- 3086US12577225B2Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2024·Granted Mar 17, 2026·0 cites·17 claims
- 3186US11008309B2Substituted benzofuranyl and benzoxazolyl compounds and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2019·Granted May 18, 2021·2 cites·20 claims
- 3285US10363247B2(S,E)-3-(6-aminopyridin-3-yl)-N-((5-(4-(3-fluoro-3-methylpyrrolidine-1-carbonyl)phenyl-7-(4-fluorophenyl)benzofuran-2-yl)methyl)acrylamide for the treatment of cancerKARYOPHARM THERAPEUTICS INC·Filed 2016·Granted Jul 30, 2019·5 cites·15 claims
- 3383US2024376114A1Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3482US9938258B2Substituted 2,3-dihydrobenzofuranyl compounds and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2013·Granted Apr 10, 2018·6 cites·12 claims
- 3581US2026062391A1Hydrazide containing nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3680US2026085064A1Substituted benzofuranyl and benzoxazolyl compounds and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3774US12331040B2Substituted benzofuranyl and benzoxazolyl compounds and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2021·Granted Jun 17, 2025·0 cites·31 claims
- 3872US2022056038A1Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3970US10858347B2Multicyclic compounds and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2016·Granted Dec 8, 2020·1 cites·31 claims
- 4066US2022168393A1Il-12 compositions and methods of use in hematopoietic recoveryKARYOPHARM THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4163US2020087313A1Nuclear transport modulators and uses thereofKARYOPHARM THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4260US12559478B2Co-crystal forms of selinexorKARYOPHARM THERAPEUTICS INC·Filed 2021·Granted Feb 24, 2026·0 cites·19 claims
- 4358US12318386B2Combination of XPO1 inhibitors and second agents for the treatment of prostate cancerKARYOPHARM THERAPEUTICS INC·Filed 2019·Granted Jun 3, 2025·0 cites·8 claims
- 4458US2024287041A1Methods of synthesis of heteroaryl derivatives of triazolyl acrylamides and crystalline formsKARYOPHARM THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4557US2017137430A1Nuclear Transport Modulators And Uses ThereofKARYOPHARM THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4654US12479806B2Process for preparing XPO1 inhibitors and intermediates for use in the preparation of XPO1 inhibitorsKARYOPHARM THERAPEUTICS INC·Filed 2020·Granted Nov 25, 2025·0 cites·12 claims
- 4749US2023391754A1Crystalline form of selinexorKARYOPHARM THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4846US2022178927A1Biomarkers for selinexorKARYOPHARM THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4942US2016016916A1Exo Olefin-Containing Nuclear Transport Modulators and Uses ThereofKARYOPHARM THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 5038US2019218207A13-(Pyridin-3-yl)-Acrylamide and N-(Pyridin-3-yl)-Acrylamide Derivatives and Their Use as PAK or NAMPT ModulatorsKARYOPHARM THERAPEUTICS INC·Filed 2016·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when KARYOPHARM THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →